PARATEK PHARMACEUTICALS INC - COM (PRTK) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2014 to Q3 2023

Type / Class
Equity / COM
Symbol
PRTK
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of PARATEK PHARMACEUTICALS INC - COM (PRTK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q3 0 $0 -$46,504,057 0
2023 Q2 20,976,316 $46,357,309 -$7,081,588 $2.21 64
2023 Q1 23,255,389 $59,046,370 +$5,498,868 $2.54 61
2022 Q4 22,760,195 $42,556,232 -$1,370,362 $1.87 76
2022 Q3 23,270,933 $59,803,633 +$2,305,057 $2.57 69
2022 Q2 21,786,780 $42,049,787 -$10,864,399 $1.93 80
2022 Q1 27,633,671 $82,087,252 +$5,109,056 $2.97 95
2021 Q4 25,418,396 $114,077,394 +$5,354,605 $4.49 97
2021 Q3 23,930,363 $116,293,798 -$3,754,677 $4.86 99
2021 Q2 24,414,126 $166,473,464 +$2,847,066 $6.82 113
2021 Q1 23,990,608 $169,358,027 +$2,435,138 $7.06 103
2020 Q4 23,661,212 $148,114,250 +$4,307,089 $6.26 103
2020 Q3 22,375,841 $121,038,384 +$6,362,643 $5.41 95
2020 Q2 21,229,537 $110,803,459 +$14,908,053 $5.22 96
2020 Q1 18,671,540 $58,771,067 -$16,365,673 $3.15 81
2019 Q4 22,884,712 $92,206,989 -$788,579 $4.03 89
2019 Q3 22,797,174 $98,496,291 -$1,864,360 $4.32 85
2019 Q2 23,466,974 $93,518,268 -$5,768,501 $3.99 83
2019 Q1 24,796,556 $132,923,810 +$3,751,286 $5.36 90
2018 Q4 24,054,650 $123,435,000 -$5,749,599 $5.13 98
2018 Q3 24,411,656 $236,737,244 -$5,648,302 $9.70 101
2018 Q2 25,002,861 $254,961,772 -$4,739,153 $10.20 107
2018 Q1 22,284,366 $289,700,164 +$10,291,928 $13.00 113
2017 Q4 23,403,724 $418,963,572 -$32,760,264 $17.90 115
2017 Q3 24,281,746 $608,946,889 +$23,038,207 $25.10 132
2017 Q2 23,444,503 $563,551,997 +$71,635,342 $24.10 117
2017 Q1 20,652,753 $397,500,502 +$69,336,872 $19.25 100
2016 Q4 18,316,483 $282,008,723 +$11,570,641 $15.40 92
2016 Q3 17,125,975 $222,802,391 -$6,881,495 $13.01 82
2016 Q2 17,580,416 $244,524,138 +$47,624,409 $13.91 90
2016 Q1 14,113,909 $214,063,000 +$5,981,831 $15.17 61
2015 Q4 13,667,316 $259,267,669 -$4,693,323 $18.97 62
2015 Q3 13,898,642 $264,046,961 +$7,402,471 $19.00 58
2015 Q2 10,631,739 $273,962,309 +$104,659,126 $25.77 66
2015 Q1 6,551,905 $204,178,000 +$5,112,928 $31.26 35
2014 Q4 6,306,747 $236,128,000 +$225,628,205 $38.55 33
2014 Q3 162,852 $330,000 +$330,000 $2.03 1